Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Systemic and Topical Antiviral Control of Cytomegalovirus Anterior Uveitis: Treatment Outcomes - Trials I and II

NCT07513623 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT07513623
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07513623 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Systemic and Topical Antiviral Control of Cytomegalovirus Anterior Uveitis: Treatment Outcomes - Trials I and II
Lead sponsor
University of California, San Francisco
Phase
Phase 2
Overall status
Not yet recruiting
Start date
November 1, 2026
Completion date
October 31, 2032
Enrollment
117 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

anterior uveitis, cmv infection, cytomegalovirus (cmv), infectious uveitis